Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GSPT1 is a translation termination factor that plays a central role in mRNA translation by facilitating the termination phase of protein synthesis. Beyond translation, it regulates the G1/S checkpoint of the cell cycle and contributes to tumorigenesis by promoting cell cycle progression. It has been linked to poor prognosis in cancers like colon and liver cancer, making it a target for anticancer drug development.
Inhibition of GSPT1 leads to reduced proliferation and increased apoptosis in tumor cells, impacting cell cycle progression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G1 to S phase transition 1 protein (GSPT1).